NEUARTIGE FAP-INHIBITOREN
Patent europeic · EP2804859 · En vigur
Inscripziun en il register
- Numer da publicaziun
- EP2804859
- Numer da la dumonda
- EP13701410
- Gener
- Patent europeic cun effect per la Svizra ed il Liechtenstein
- Status
- En vigur
- Scrittira da patent
- Concedì
- Annunzià
- 17-01-2013
- Publitgà
- 26-11-2014
- Concedì
- 12-06-2019
- La protecziun finescha il pli tard
- 16-01-2033
- Proxima taxa annuala scadenta
- 31-01-2027
- Classas IPC
- C07D 401/12 (2006.01)C07D 403/12 (2006.01)C07D 413/12 (2006.01)C07D 417/12 (2006.01)C07D 471/04 (2006.01)A61K 31/401 (2006.01)A61P 35/00 (2006.01)
- Prioritad
- GB 201200705 17.01.2012GB 201220458 14.11.2012
- Dumonda PCT
- PCT/EP2013/050845 17.01.2013
- Publicaziun PCT
- WO2013/107820 25.07.2013
- Lingua da l’annunzia
- englais
- Funtauna
- Swissreg
Istorgia
Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.
- 01-02-2026
Midada
Published in Swissreg on 01.02.2026
- 01-02-2025
Midada
Published in Swissreg on 01.02.2025
- 01-02-2024
Midada
Published in Swissreg on 01.02.2024
- 01-02-2023
Midada
Published in Swissreg on 01.02.2023
- 21-06-2022
Transferì
- Owner
- Universiteit Antwerpen, Prinsstraat 13, 2000 Antwerpen, Belgium, FOX CHASE CANCER CENTER, 333 Cottman Avenue, Philadelphia, PA 19111, USA → Universiteit Antwerpen, Prinsstraat 13, 2000 Antwerpen, Belgium, The Institute for Cancer Research, 333 Cottman Avenue, Philadelphia PA 19111, USA
Published in Swissreg on 21.06.2022
- 12-06-2019
Concedì
Published in Swissreg on 12.06.2019
Partidas
Possessur
Inventur
2610 Wilrijk, BE
Philadelphia, Pennsylvania 19111, US
2980 Zoersel, BE
2610 Wilrijk, BE
2610 Wilrijk, BE
2560 Sint-Katelijne Waver, BE
2610 Wilrijk, BE
Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.